Inventor · disambiguated record
Angela Virone-Oddos
Also filed as: VIRONE-ODDOS ANGELA
4 granted patents·10 pending applications·3 citations·filing 2012–2025
61Inventor score
Top patents by PatentIndex Score
14 records- 0189US11692039B2Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123INNATE PHARMA·Filed 2021·Granted Jul 4, 2023·2 cites·22 claims
- 0286US12195555B2Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineeringSANOFI SA·Filed 2023·Granted Jan 14, 2025·1 cites·33 claims
- 0374US2025197528A1NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERINGSANOFI SA·Filed 2024·Application pending·0 cites
- 0471US12286475B2Anti-GPRC5D antibodies and compositionsSANOFI SA·Filed 2024·Granted Apr 29, 2025·0 cites·20 claims
- 0568US2023416383A1MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND CD123INNATE PHARMA·Filed 2023·Application pending·0 cites
- 0665US2023416395A1Anti-cd38 antibodies and formulationsSANOFI SA·Filed 2023·Application pending·0 cites
- 0764US2025064935A1Natural killer cells and cd123 nk cell engager combination therapySANOFI SA·Filed 2024·Application pending·0 cites
- 0859US2025195653A1Multifunctional natural killer (nk) cell engager combination therapy for treating hematological neoplastic disordersSANOFI SA·Filed 2024·Application pending·0 cites
- 0958US11655302B2Anti-CD38 antibodies and formulationsSANOFI SA·Filed 2020·Granted May 23, 2023·0 cites·24 claims
- 1053US2025230234A1Anti-gprc5d antibodies and compositionsSANOFI SA·Filed 2025·Application pending·0 cites
- 1152US2025177519A1Use of isatuximab in combination with other agents for the treatment of multiple myelomaSANOFI AVENTIS US LLC·Filed 2023·Application pending·0 cites
- 1237US2014275078A1Compositions and methods for treating cancer using pi3kb inhibitor and mapk pathway inhibitor, including mek and raf inhibitorsGARCIA-ECHEVERRIA CARLOS·Filed 2012·Application pending·0 cites
- 1336US2016030440A1Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitorSANOFI SA·Filed 2014·Application pending·0 cites
- 1436US2016030438A1Anti-tumoral composition comprising a pi3kbeta inhibitor and a raf inhibitor, to overcome cancer cells resistanceSANOFI SA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angela Virone-Oddos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →